Philip Seeman

2.1k total citations · 1 hit paper
16 papers, 1.7k citations indexed

About

Philip Seeman is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Philip Seeman has authored 16 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 5 papers in Psychiatry and Mental health. Recurrent topics in Philip Seeman's work include Receptor Mechanisms and Signaling (11 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Schizophrenia research and treatment (3 papers). Philip Seeman is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Schizophrenia research and treatment (3 papers). Philip Seeman collaborates with scholars based in Canada, United States and Jamaica. Philip Seeman's co-authors include Shitij Kapur, Carla Ulpian, Mary V. Seeman, Bruce K. Christensen, Alan A. Wilson, G. Remington, S. Silvestri, Chekkera Shammi, Sylvain Houle and José N. Nóbrega and has published in prestigious journals such as American Journal of Psychiatry, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Philip Seeman

16 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Does Fast Dissociation From the Dopamine D₂Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis

2001 841 citations Shitij Kapur, Philip Seeman American Journal of Psychiatry profile →

Peers

Countries citing papers authored by Philip Seeman

Since Specialization

Citations

This map shows the geographic impact of Philip Seeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Seeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Seeman more than expected).

Fields of papers citing papers by Philip Seeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Seeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Seeman. The network helps show where Philip Seeman may publish in the future.

Co-authorship network of co-authors of Philip Seeman

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Seeman. A scholar is included among the top collaborators of Philip Seeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Seeman. Philip Seeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Does Fast Dissociation From the Dopamine D₂Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis breakdown → 2001 ·American Journal of Psychiatry ·Shitij Kapur, Philip Seeman	841
2	Idiopathic environmental intolerance: Increased prevalence of panic disorder–associated cholecystokinin B receptor allele 7 2001 ·Journal of Allergy and Clinical Immunology ·Karen Binkley, Nicole King, Naveen Poonai, Philip Seeman, Carla Ulpian, James L. Kennedy	41
3	Increased dopamine D 2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study 2000 ·Psychopharmacology ·S. Silvestri, Mary V. Seeman, (unknown), Sylvain Houle, Chekkera Shammi, G. Remington, Shitij Kapur, (unknown), Alan A. Wilson, Bruce K. Christensen, Philip Seeman	235
4	Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors 1997 ·Neuropsychopharmacology ·Philip Seeman	185
5	Dopamine D4 receptor variant in Africans, D4Valine194Glycine, is insensitive to dopamine and clozapine: Report of a homozygous individual 1996 ·American Journal of Medical Genetics ·Ivy S.C Liu, Philip Seeman, Suparna Sanyal, Carla Ulpian, (unknown), G. R. Serjeant, Hubert H.M. Van Tol	47
6	Binding of 5H-Dibenzo[a,d]cycloheptene and Dibenz[b,f]oxepin Analogs of Clozapine to Dopamine and Serotonin Receptors 1995 ·Journal of Medicinal Chemistry ·(unknown), Tomas de Paulis, Jon R. Neergaard, Bruce M. Baron, Barry W. Siegel, Philip Seeman, Hubert H.M. Van Tol, Hong‐Chang Guan, Howard E. Smith	20
7	The Human Dopamine D5 Receptor Gene: Cloning and Characterization of the 5'-Flanking and Promoter Region 1995 ·Biochemistry ·Timothy V. Beischlag, Adriano Marchese, James H. Meador‐Woodruff, S.P. Damask, Brian F. O’Dowd, Rachel F. Tyndale, (unknown), Philip Seeman, Hyman B. Niznik	51
8	Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians: No association with Schizophrenia 1994 ·American Journal of Medical Genetics ·Philip Seeman, Carla Ulpian, Guy Chouinard, Hubert H.M. Van Tol, (unknown), J.A. Lieberman, (unknown), Ivy S.C Liu, John S. Waye, (unknown), Craig J. Hudson, G. R. Serjeant, Arni S. Masibay, Mary V. Seeman	59
9	Dopamine D2 receptors mapped in rat brain with [³H](+)PHNO 1994 ·Synapse ·José N. Nóbrega, Philip Seeman	35
10	Human dopamine D5 receptor pseudogenes 1991 ·Gene ·Tuan Nguyen, Jonathan Bard, Hui Jin, Domenica Taruscio, (unknown), James L. Kennedy, Richard L. Weinshank, Philip Seeman, Brian F. O’Dowd	44
11	(.+-.)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine, a new high affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship 1991 ·Journal of Medicinal Chemistry ·John L. Neumeyer, (unknown), Hyman B. Niznik, H C Guan, Philip Seeman	18
12	2-Haloaporphines as potent dopamine agonists 1989 ·Journal of Medicinal Chemistry ·(unknown), John L. Neumeyer, Dimitri E. Grigoriadis, Philip Seeman	26
13	Dopamine D2 Receptors Retain Agonist High-Affinity Form and Guanine Nucleotide Sensitivity after Removal of Sialic Acid1 1988 ·The Journal of Biochemistry ·Keith R. Jarvie, Hyman B. Niznik, (unknown), Philip Seeman	3
14	Photoaffinity labeling of dopamine D1 receptors 1988 ·Biochemistry ·Hyman B. Niznik, Keith R. Jarvie, (unknown), Philip Seeman, Russell Garlick, (unknown), (unknown), John L. Neumeyer	23
15	Dopamine D1 and D2 Receptor Selectivities of Agonists and Antagonists 1988 ·Advances in experimental medicine and biology ·Philip Seeman, Carla Ulpian	42
16	Dopamine D1 receptors with enhanced agonist affinity and reduced antagonist affinity revealed by chemical modification 1988 ·Biochemical and Biophysical Research Communications ·Natalie Bzowej, Hyman B. Niznik, Philip Seeman	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact